Patient Factors Associated with Titration of Medical Therapy in Patients with Heart Failure with Reduced Ejection Fraction: Data from the QUALIFY International Registry
ESC Heart Failure2021Vol. 8(2), pp. 861–871
Citations Over TimeTop 10% of 2021 papers
Martín Cowie, Jakob Schöpe, Stefan Wagenpfeil, Luigi Tavazzi, Michael Böhm, Piotr Ponikowski, Stefan D. Anker, Gerasimos Filippatos, Michel Komajda, QUALIFY Investigators
Abstract
The international QUALIFY Registry suggests that few patients with HFrEF achieve target doses of disease-modifying medication, especially older patients and those with co-morbidity. Quality improvement initiatives are urgently required.
Related Papers
- → Characterization of the Heart Rate-Lowering Action of Ivabradine, a Selective I f Current Inhibitor(2008)59 cited
- → The therapeutic role of ivabradine in heart failure(2018)32 cited
- → Clinical Efficacy of Ivabradine(2005)4 cited
- Ivabradine, A Heart Rate Lowering Drug: A Clinical Investigation(2014)
- Advances in Using Ivabradine in Cardiovascular Disease(2012)